๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 13 Shanhai 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai13 Shanhai1
All 2 locations
Target enrolment
to

Trials with a site in Shanghai

13 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Multicentric Database for KRAS Mutant Pancreatic Cancer
NCT07557849Pancreatic Cancer
Fudan University
Observational
1,000
Shanghai
2026-05-22
Not yet open
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes
NCT07272109Pancreatic Cancer
Fudan University
Phase 3
210
Shanghai
2026-01-01
Recruiting
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
NCT06601283Pancreatic Cancer
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
NCT06598033Pancreatic Cancer
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer
NCT06547736Pancreatic Cancer
Fudan University
Phase 2
160
Shanghai
2024-10-14
Active, closed
First-line Regimen With QL1706 Plus Chemo ยฑ Bev in PDAC Patients
NCT06313970Pancreatic Cancer
Fudan University
Phase 2
58
Shanghai
2024-06-20
Not yet open
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
NCT06370754Pancreatic Cancer
Fudan University
Phase 1/2
117
Shanghai
2024-04-30
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
NCT06249321Pancreatic Cancer, Radiotherapy
Fudan University
Phase 2
30
Shanghai
2024-04-01
Recruiting
Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer
NCT06196788Pancreatic Cancer
Fudan University
Phase 2
30
Shanghai
2024-03-01
Not yet open
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
NCT06156267Pancreatic Cancer
Fudan University
Phase EARLY_PHASE1
30
Shanghai
2024-01
Recruiting
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147Pancreatic Cancer
Fudan University
Observational
276
Shanghai
2023-12-18
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Shanghai that also match the filters currently applied.

How many clinical trials are recruiting in Shanghai?

8 of the 13 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shanghai), 13 studies
PhaseStudiesRecruitingShare
Phase 24330.8%
Observational2215.4%
Phase 1/22115.4%
Phase 2/32215.4%
Phase 32015.4%
Phase EARLY_PHASE1107.7%

Most active sponsors

Lead sponsors with the most studies (Shanghai)
Lead sponsorStudiesRecruiting
Fudan University138
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.